NOVEL PD-L1 TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY

• 收藏
• 分享

专利权人:

VAXIMM AG

发明人:

Heinz Lubenau

申请号：

US16494629

公开号：

US20200085928A1

申请日:

2018.03.16

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention relates to an attenuated strain of Salmonella comprising at least one copy of a DNA molecule comprising an expression cassette encoding PD-L1. In particular, the present invention relates to said attenuated strain of Salmonella for use in the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/